📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
Latest filing: 2026-08-04 16:06
510 analysed today
510
Today
133,399
All-time analysed
40,108
Positive
6,279
Negative
79,197
Neutral
7,747
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
19 announcements match the current filters (relevance ≥ 5).
CARE Downgrades GACL Long-Term Rating to 'AA-' on Weak Financial Performance
CARE Ratings has downgraded Gujarat Alkalies and Chemicals Limited's (GACL) long-term rating from 'CARE AA; Stable' to 'CARE AA-; Stable'. The downgrade follows two consecutive years of lower-than-expected financial performance, with TTM PAT dropping to just Rs 6 Cr on a revenue of Rs 4,358 Cr. The agency cited moderate caustic soda prices, negative chlorine realizations, and a slower-than-envisaged ramp-up of the GNAL joint venture as primary reasons. While Q1FY27 showed some margin improvement, the sustainability of this recovery remains uncertain due to industry cyclicality.
Confidence: HIGH
What changedGACL's long-term credit rating was lowered by one notch due to prolonged financial underperformance and failure to meet previous rating sensitivity thresholds regarding profitability and debt coverage.
Why it mattersA credit rating downgrade typically increases the cost of borrowing and signals to the market that the company's financial risk profile has deteriorated, primarily due to the cyclical downturn in the chlor-alkali industry.
Long-term Rated Debt: Rs 372.63 CrTTM PAT: Rs 6 CrDebt to Net Worth Ratio: 0.10Average Power Cost (FY26): Rs 7.90 per unitCaustic Soda Capacity: ~3,000 MTPD
📅 Short termThe downgrade may lead to short-term negative sentiment in the stock, although the underlying weak financial performance was already visible in recent quarterly results.
📈 Long termStructural recovery depends on the company's ability to diversify into value-added chemicals and the stabilization of global caustic soda prices to improve ECU realizations.
⚠ Risk flags
- Cyclicality of chlor-alkali industry
- Negative chlorine realisations
- Volatility in energy prices
- Slower-than-expected ramp-up of GNAL JV
Key Highlights
Long-term bank facilities of Rs 372.63 Cr downgraded to CARE AA- (Stable) from CARE AA (Stable).
Consolidated TTM PAT stands at Rs 6 Cr against a revenue base of Rs 4,358 Cr, reflecting severe margin pressure.
Renewable energy contribution increased to ~35% of total power requirements, reducing average power cost to Rs 7.90 per unit in FY26.
GNAL JV utilization improved to 82% in Q4 FY24, but overall financial contribution remains below previous expectations.
Short-term bank facilities of Rs 339.50 Cr and Commercial Paper of Rs 100 Cr reaffirmed at CARE A1+.
👀 What to Watch
Investors should monitor the Electrochemical Unit (ECU) realizations and the progress of the GNAL JV toward its 85-90% capacity utilization target. The key to a rating upgrade will be a sustained PBILDT margin above 12% and a reduction in consolidated Total Debt/PBILDT below 1.50x.
CARE Downgrades GUJALKALI Long-Term Rating to 'AA-; Stable' from 'AA'
CARE Ratings has downgraded Gujarat Alkalies and Chemicals Limited's (GACL) long-term bank facilities of Rs 372.63 Cr to 'CARE AA-; Stable' from 'CARE AA; Stable'. The downgrade follows a review of FY26 audited and Q1FY27 unaudited performance, reflecting a period of thin profitability with TTM PAT at just Rs 6 Cr. Short-term ratings for bank facilities (Rs 339.50 Cr) and Commercial Paper (Rs 100 Cr) were reaffirmed at 'CARE A1+'. The company has requested the rating agency to provide detailed reasons for the long-term downgrade.
Confidence: HIGH
What changedCARE Ratings lowered the company's long-term credit rating by one notch while maintaining a stable outlook and reaffirming short-term ratings.
Why it mattersA credit downgrade typically reflects a perceived increase in credit risk or deteriorating financial health, which can lead to higher borrowing costs and impact investor sentiment, especially given the company's low TTM PAT of Rs 6 Cr.
Long-term facilities downgraded: Rs 372.63 CrShort-term facilities reaffirmed: Rs 339.50 CrCommercial Paper rating: CARE A1+TTM PAT: Rs 6 CrDebt-to-Equity Ratio: 0.10
📅 Short termThe stock may face negative sentiment in the coming days as the downgrade highlights the financial impact of the current cyclical downturn in the chlor-alkali industry.
📈 Long termStructural recovery depends on the successful ramp-up of the GNAL JV to 85-90% capacity and a sustained rebound in global caustic soda prices to improve operating margins from the current 8.8%.
⚠ Risk flags
- Cyclicality of chlor-alkali prices
- Low interest coverage due to thin margins
- Chlorine disposal risks at GNAL JV
Key Highlights
Long-term bank facilities of Rs 372.63 Cr downgraded to 'CARE AA-; Stable' from 'CARE AA; Stable'.
Short-term bank facilities of Rs 339.50 Cr reaffirmed at 'CARE A1+'.
Commercial Paper issue of Rs 100 Cr reaffirmed at 'CARE A1+'.
Long-term rated amount reduced to Rs 372.63 Cr from the previous Rs 482.34 Cr.
Ratings review based on FY26 audited and Q1FY27 unaudited financial performance.
👀 What to Watch
Investors should monitor the detailed rating rationale from CARE when released to identify specific triggers for the downgrade, such as margin pressure or GNAL JV performance. Watch for improvements in Electrochemical Unit (ECU) realizations in upcoming quarterly results.
83% EBITDA Growth and Highest-Ever Quarterly Revenue of ₹1,224.84 Cr in Q1 FY27
GUJALKALI reported a strong turnaround in Q1 FY27, achieving its highest-ever quarterly revenue of ₹1,224.84 Cr, a 14% YoY increase. EBITDA surged 83% to ₹229 Cr, while Profit Before Tax (PBT) jumped 1000% to ₹110 Cr from ₹10 Cr YoY. This performance was driven by product mix optimization, new export markets, and a significant increase in renewable energy usage, which now accounts for 59% of the power basket. Additionally, the board approved a ₹55 Cr HCL synthesis unit to improve chlorine utilization.
Confidence: HIGH
What changedThe company has moved from a period of volatile/low profitability to record-high quarterly revenues and a massive jump in PBT, supported by a higher share of green energy.
Why it mattersThe chemical industry is energy-intensive and cyclical; GUJALKALI's move to 59% renewable energy and focus on chlorine-utilizing downstream products (HCL) helps insulate margins from power cost spikes and commodity price swings.
Q1 FY27 Revenue: ₹1,224.84 CrEBITDA Growth (YoY): 83%Renewable Energy Share: 59%New Project Cost (HCL Unit): ₹55 CrQ1 Revenue vs TTM Revenue: 28.1%New Project vs Net Worth: 0.98%
📅 Short termThe stock is likely to react positively to the sharp recovery in PBT and record revenue, especially given the low TTM PAT of ₹6 Cr.
📈 Long termStructural improvements in energy costs and the expansion into value-added products like Phosphoric Acid could lead to a re-rating if the company maintains this level of operational efficiency.
⚠ Risk flags
- Cyclicality of chlor-alkali prices
- Chlorine disposal risks at GNAL JV
- Execution risk for new capacity projects
Key Highlights
Highest-ever quarterly revenue of ₹1,224.84 Cr, up 14% from ₹1,073.45 Cr YoY
EBITDA increased by 83% to ₹229 Cr compared to ₹125 Cr in the previous year's quarter
Profit Before Tax (PBT) rose by 1000% to ₹110 Cr from ₹10 Cr YoY
Renewable energy share in the power basket increased significantly to 59% from 39% YoY
In-principle approval for a new HCL synthesis unit at Dahej with an estimated cost of ₹55 Cr
👀 What to Watch
Investors should monitor the sustainability of the improved margins and the execution timeline of the ₹55 Cr HCL unit and the upcoming Phosphoric Acid plant. The shift toward 59% renewable energy is a key structural cost-saving measure to watch in future quarters.
Rs 55 Cr In-Principle Approval for New HCL Synthesis Unit at Dahej
Gujarat Alkalies and Chemicals Limited (GACL) has received in-principle board approval for a new HCL synthesis unit at its Dahej complex with an estimated cost of Rs 55 Crores. This unit is strategically designed to improve chlorine utilization, a critical byproduct management step that currently limits caustic soda production capacity. The additional HCL produced will serve as a feedstock for the company's planned Phosphoric Acid plant at the same location. While the investment is relatively small at ~1.26% of TTM revenue, it addresses a key operational bottleneck regarding chlorine disposal.
Confidence: HIGH
What changedThe board has moved from planning to in-principle approval for a specific downstream unit to handle byproduct chlorine.
Why it mattersChlorine disposal is a major risk for chlor-alkali players; by converting chlorine into HCL for internal phosphoric acid production, GACL can run its caustic soda plants at higher utilization without being limited by chlorine storage or disposal constraints.
Project Cost: Rs 55 CroresTTM Revenue: Rs 4358 CrCapex vs TTM Revenue: ~1.26%Net Worth: Rs 5570 CrCapex vs Net Worth: ~0.99%
📅 Short termThe announcement is likely to be viewed neutrally to slightly positively by the market as it demonstrates a clear path toward solving operational constraints, though immediate financial impact is minimal.
📈 Long termStructurally positive as it integrates the Dahej complex further, reducing dependence on external chlorine buyers and supporting the shift toward value-added chemicals like Phosphoric Acid.
⚠ Risk flags
- Execution risk of the integrated Phosphoric Acid project
- Cyclicality of chlor-alkali prices
Key Highlights
Board granted in-principle approval for a new HCL synthesis unit at Dahej with a project cost of ~Rs 55 Crores.
The unit aims to optimize Caustic Soda production by enhancing chlorine utilization, addressing a known industry bottleneck.
Produced HCL will be utilized internally for a previously approved Phosphoric Acid plant at Dahej.
The project cost represents approximately 1.26% of the company's TTM revenue of Rs 4,358 Crores.
Investment accounts for roughly 0.99% of the company's Net Worth of Rs 5,570 Crores.
👀 What to Watch
Investors should monitor the execution timeline for both this HCL unit and the associated Phosphoric Acid plant, as the synergy between these units is key to improving overall capacity utilization.
₹54.98 Cr Q1 Net Profit: GUJALKALI reports turnaround and ₹55 Cr HCL unit expansion
GUJALKALI reported a significant turnaround in Q1 FY27, posting a consolidated net profit of ₹54.98 Cr compared to a loss of ₹13.78 Cr in the same quarter last year. Revenue from operations grew 12.6% YoY to ₹1,244.91 Cr, driven by improved performance and better utilization. The board also approved a new HCL synthesis unit at Dahej with an estimated cost of ₹55 Cr to optimize chlorine utilization and caustic soda production. Notably, the GNAL joint venture turned profitable, contributing ₹1.58 Cr to the bottom line versus a loss of ₹21.57 Cr in the year-ago period.
Confidence: HIGH
What changedGUJALKALI has returned to profitability after a period of losses, supported by a turnaround in its major joint venture and a new strategic capex for byproduct management.
Why it mattersThe turnaround is crucial as the company has been struggling with industry-wide oversupply and low realizations; the new HCL unit helps decouple caustic soda production from chlorine disposal constraints.
Q1 Consolidated Net Profit: ₹54.98 CrQ1 Revenue Growth (YoY): 12.6%HCL Unit Project Cost: ₹55 CrProject Cost vs TTM Revenue: 1.26%JV Profit Contribution: ₹1.58 Cr
📅 Short termThe stock is likely to react positively to the sharp turnaround in earnings and the return to profitability of the GNAL JV.
📈 Long termLong-term value depends on the execution of 'Vision 2047' and the company's ability to shift toward value-added chemicals to mitigate chlor-alkali price cyclicality.
⚠ Risk flags
- Cyclicality of caustic soda prices
- High power and fuel costs (highlighted by the ₹16.65 Cr one-time charge)
- Chlorine disposal risks
Key Highlights
Consolidated Net Profit reached ₹54.98 Cr in Q1 FY27, reversing a loss of ₹13.78 Cr in Q1 FY26.
Revenue from operations increased to ₹1,244.91 Cr, up 12.6% from ₹1,105.12 Cr in the previous year's quarter.
Approved ₹55 Cr investment for a new HCL synthesis unit at Dahej to enhance chlorine disposal and caustic soda output.
Joint Venture (GNAL) share of profit turned positive at ₹1.58 Cr compared to a loss of ₹21.57 Cr YoY.
Power costs for the quarter include a one-time differential energy charge of ₹16.65 Cr for the period 2018-2023.
👀 What to Watch
Investors should monitor the sustainability of the turnaround in the GNAL JV and the progress of the HCL unit, which addresses the critical 'chlorine disposal' bottleneck for caustic soda production.
GUJALKALI Invests ₹32.33 Cr to Maintain 26% Stake in Cleanmax Sphere Energy SPV
Gujarat Alkalies and Chemicals Limited (GACL) has contributed ₹32.33 crore to the rights issue of Cleanmax Sphere Energy Private Limited to maintain its 26% equity stake. The investment involved the acquisition of 15,77,063 equity shares at a price of ₹205 per share (including a ₹195 premium). This Special Purpose Vehicle (SPV) is developing a 75.9 MW Renewable Hybrid Power Project dedicated to 100% captive use by GACL. The move is aimed at securing green energy and optimizing long-term power costs for the company's operations.
Key Highlights
Invested ₹32,32,97,915 to maintain a 26% shareholding in Cleanmax Sphere Energy Private Limited.
Acquired 15,77,063 equity shares at a price of ₹205 per share (Face Value ₹10 + Premium ₹195).
The SPV is setting up a 75.9 MW Renewable Hybrid Power Project for 100% captive consumption.
The target entity was incorporated in 2020 and is yet to commence commercial operations.
This investment follows a series of capital contributions initiated in late 2025 to fund the green energy project.
👀 What to Watch
Investors should monitor the commissioning timeline of the 75.9 MW hybrid project as it is expected to reduce power costs and improve the company's ESG profile.
GACL Partners with CleanMax for 160.24 MW Hybrid Renewable Power Project in Gujarat
Gujarat Alkalies and Chemicals Limited (GACL) has partnered with CleanMax to establish a hybrid renewable energy project comprising 75.90 MW of wind and 84.34 MWp of solar capacity. The project will supply 100% of its generated power to GACL's Dahej and Vadodara manufacturing units under a group captive structure. Expected to generate 36.9 crore units of clean power annually, the initiative aims to significantly reduce energy costs and carbon emissions. The project is being executed in two phases across four sites in Gujarat to enhance the company's long-term operational sustainability.
Key Highlights
Total hybrid capacity of 160.24 MW (75.90 MW Wind and 84.34 MWp Solar) dedicated for 100% captive consumption.
Expected to generate 36.9 crore units of clean power annually, reducing CO2 emissions by 2,64,204 tons.
Project execution in two phases: Phase 1 (16.50 MW Wind, 21.701 MWp Solar) and Phase 2 (59.40 MW Wind, 62.64 MWp Solar).
Strategic move to lower power costs in the energy-intensive chlor-alkali manufacturing process.
Partnership with CleanMax, which has a contracted renewable portfolio of 5.7 GW as of FY 2025-26.
👀 What to Watch
Investors should monitor the commissioning timelines of the two phases as this project will likely improve GACL's margins by reducing volatile energy costs. This move also strengthens the company's ESG profile, making it more attractive to sustainability-focused institutional investors.
GUJALKALI to Invest ₹67 Cr in 5000 TPA High Purity Hydrogen Peroxide Plant at Dahej
Gujarat Alkalies and Chemicals Limited (GACL) has approved the setup of a 5000 TPA High Purity Grade Hydrogen Peroxide plant at its Dahej complex. The project requires an estimated investment of ₹67 crores and is designed to serve high-tech industries such as semiconductor fabrication and solar cell manufacturing. The facility is expected to be operational within 18 months and contribute approximately ₹42 crores to annual sales revenue. Funding will be sourced from internal accruals and debt if necessary.
Key Highlights
Investment of ₹67 crores for a 5000 TPA High Purity Grade Hydrogen Peroxide facility
Projected annual revenue contribution of approximately ₹42 crores upon completion
Targeting niche applications in semiconductor fabrication and solar cell manufacturing
Execution timeline set for 18 months from the project kick-off date
Funding via surplus internal operations and need-based borrowings
👀 What to Watch
Investors should view this as a positive move into high-margin specialty chemicals that align with India's semiconductor and solar manufacturing push. Monitor the 18-month execution timeline for potential revenue realization in late 2027.
GUJALKALI Recommends Rs 17.70 Dividend; FY26 PAT Rises to Rs 20.84 Cr; New Dahej Plant Approved
Gujarat Alkalies and Chemicals (GACL) reported a 7% increase in annual revenue to Rs 4,358 crore for FY26, with PAT growing to Rs 20.84 crore from Rs 15.82 crore. The Board recommended a substantial final dividend of Rs 17.70 per share (177%), signaling strong shareholder returns despite valuation-driven comprehensive losses. Additionally, the company approved a Rs 67 crore investment for a 5,000 TPA High Purity Hydrogen Peroxide plant at Dahej to target the semiconductor and solar sectors. This project is expected to generate Rs 42 crore in annual revenue within 18 months of commencement.
Key Highlights
Recommended a final dividend of Rs 17.70 per equity share (177%) for the financial year ended March 31, 2026.
Annual Revenue from Operations grew 7% YoY to Rs 4,358.08 crore compared to Rs 4,072.91 crore in FY25.
Profit After Tax (PAT) increased to Rs 20.84 crore for FY26, up from Rs 15.82 crore in the previous year.
Approved a new 5,000 TPA High Purity Grade Hydrogen Peroxide plant at Dahej with an investment of Rs 67 crore.
The new plant targets niche applications in semiconductor and solar cell manufacturing with an expected annual revenue contribution of approx. Rs 42 crore.
👀 What to Watch
The high dividend payout and strategic entry into high-purity chemicals for the semiconductor industry are positive long-term catalysts. Investors should hold for the dividend yield while monitoring the execution of the Dahej expansion and the performance of the GACL-NALCO joint venture.
GACL FY26 PAT Grows to ₹20.8 Cr; Recommends ₹17.70 Dividend & ₹67 Cr Dahej Expansion
Gujarat Alkalies and Chemicals Limited (GACL) reported a standalone net profit of ₹20.84 crore for FY26, an increase from ₹15.82 crore in FY25. The Board has recommended a substantial dividend of ₹17.70 per share (177%), signaling strong cash flow management. A key strategic highlight is the approval of a ₹67 crore investment for a 5,000 TPA high-purity Hydrogen Peroxide plant at Dahej, targeting the semiconductor and solar cell industries. While annual revenue rose to ₹4,358 crore, Q4 standalone profit dipped to ₹7.93 crore compared to ₹21.38 crore in the year-ago quarter, primarily due to rising power and fuel expenses.
Key Highlights
Standalone FY26 Revenue from Operations grew to ₹4,35,808 lakhs from ₹4,07,291 lakhs in the previous year.
Recommended a final dividend of ₹17.70 per equity share (177%) for the financial year ended March 31, 2026.
Approved a ₹67 crore investment for a 5,000 TPA High Purity Grade Hydrogen Peroxide plant at Dahej for semiconductor fabrication.
The new Dahej project is expected to contribute approximately ₹42 crores to annual sales revenue once operational (18-month timeline).
Standalone Profit After Tax for FY26 increased to ₹2,084 lakhs compared to ₹1,582 lakhs in FY25.
👀 What to Watch
Investors should focus on the high dividend payout and the company's strategic entry into the high-margin semiconductor supply chain. While Q4 margins were pressured by utility costs, the long-term outlook is supported by niche capacity expansions and steady revenue growth.
GUJALKALI Board to Meet on May 29 for Q4 FY26 Results and Dividend Recommendation
Gujarat Alkalies and Chemicals Limited (GUJALKALI) has scheduled a Board Meeting on May 29, 2026, to consider and approve audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026. Crucially for shareholders, the board will also evaluate the recommendation of a dividend for the fiscal year. The trading window, which has been closed since April 1, 2026, is set to reopen on June 1, 2026, following the announcement.
Key Highlights
Board meeting scheduled for May 29, 2026, to approve Q4 and FY26 audited results
Potential dividend recommendation for the financial year ended March 31, 2026, to be discussed
Trading window for designated persons remains closed from April 1, 2026, to May 31, 2026
Trading window will officially reopen for all insiders on June 1, 2026
👀 What to Watch
Investors should monitor the May 29 results for operational performance and the specific dividend yield offered. The stock may see volatility leading up to the announcement based on dividend expectations.
Promoter GNFC Acquires 4.60 Lakh Shares of Gujarat Alkalies for Rs 22.83 Crore
Gujarat Narmada Valley Fertilizers & Chemicals Limited (GNFC), a promoter entity of Gujarat Alkalies and Chemicals Limited (GACL), has increased its stake in the company through an open market purchase. On March 20, 2026, GNFC acquired 4,60,340 equity shares, representing approximately 0.63% of the company. This transaction, valued at Rs 22.83 crore, raises GNFC's total holding from 2.77% to 3.40%. Such significant market purchases by a promoter often signal strong internal confidence in the company's valuation and future prospects.
Key Highlights
Promoter GNFC purchased 4,60,340 equity shares of GACL on March 20, 2026.
The total transaction value was Rs 22.83 crore, including all applicable charges.
GNFC's shareholding in GACL increased from 2.77% (20,34,025 shares) to 3.40% (24,94,365 shares).
The acquisition was conducted via an open market transaction on the National Stock Exchange (NSE).
The promoter has committed to a minimum holding period of six months for the newly acquired shares.
👀 What to Watch
Investors should view this promoter stake increase as a positive signal of confidence in the company's intrinsic value. It may be a good time to review the stock for potential long-term accumulation.
Promoter GNFC Acquires 2.70 Lakh Shares of Gujarat Alkalies for ₹12.88 Crore
Gujarat Narmada Valley Fertilizers & Chemicals Limited (GNFC), a key promoter of Gujarat Alkalies and Chemicals Limited (GACL), has increased its stake through open market purchases. On March 19, 2026, GNFC acquired 2,70,500 equity shares at a total value of approximately ₹12.88 crore. This move has raised GNFC's total holding in GACL from 15.26% to 15.63%. Promoter buying at market prices often indicates internal confidence in the company's valuation and future growth potential.
Key Highlights
Acquisition of 2,70,500 equity shares by promoter GNFC on March 19, 2026
Total transaction value stands at ₹12.88 crore inclusive of all charges
Promoter stake increased by 0.37%, moving from 15.26% to 15.63%
The transaction was executed via open market purchase, reflecting commitment at current market prices
👀 What to Watch
Promoter buying is typically a bullish indicator of value; investors should monitor if this leads to further consolidation by the promoter group. Maintain a positive outlook while keeping an eye on the company's quarterly operational performance.
GACL Inaugurates Hydrogen Pipeline to NOCIL; Expected Annual Revenue of Rs. 9 Crores
Gujarat Alkalies and Chemicals Limited (GACL) has successfully commissioned a new Hydrogen supply pipeline to NOCIL Limited at its Dahej facility. The company will supply approximately 20,000 Nm³/day of Hydrogen through this dedicated infrastructure. This arrangement is expected to contribute about Rs. 9 Crores to GACL's annual revenue. The two companies have entered into a 5-year supply agreement, providing long-term revenue visibility for this segment.
Key Highlights
Commissioned a dedicated Hydrogen supply pipeline to NOCIL Limited at Dahej
Agreement to supply approximately 20,000 Nm³/day of Hydrogen gas
Expected annual revenue contribution of approximately Rs. 9 Crores
Executed a 5-year supply agreement with provisions for mutual renewal
Strengthens industrial gas segment and B2B partnership with a major chemical player
👀 What to Watch
Investors should monitor GACL's ability to leverage its byproduct gases for high-value industrial supply. While the revenue impact is modest relative to total turnover, it represents a high-margin, steady cash flow stream.
GACL Approves ₹1,029 Cr Capex for Expansion & Reports Q3 Turnaround Profit of ₹13.28 Cr
Gujarat Alkalies and Chemicals (GACL) has announced a massive capital expenditure program totaling approximately ₹1,029 crore to drive future growth. Key projects include a ₹560 crore Food Grade Phosphoric Acid plant and an ₹80 crore expansion of Caustic Potash (KOH) capacity from 120 TPD to 200 TPD. On the financial front, the company reported a standalone net profit of ₹13.28 crore for Q3 FY26, a significant recovery from the ₹239.09 crore loss reported in the same quarter last year. The board also approved a ₹250 crore line of credit to support these initiatives.
Key Highlights
Approved ₹560 crore for a 33,870 TPA Food Grade Phosphoric Acid Plant with ₹350 crore annual revenue potential
Investment of ₹389 crore in 4 Biofuel/Coal boilers to reduce steam costs and generate 12 MW of power
Caustic Potash (KOH) capacity expansion from 120 TPD to 200 TPD expected to add ₹130 crore to annual revenue
Standalone Q3 FY26 Net Profit turned positive at ₹13.28 crore versus a loss of ₹239.09 crore YoY
Board approved availing a ₹250 crore Line of Credit from Gujarat State Financial Services Ltd
👀 What to Watch
The aggressive expansion into high-margin food-grade chemicals and cost-saving energy projects signals strong long-term growth potential. Investors should view the turnaround in profitability and the massive capex as a positive indicator for the stock's long-term trajectory.
GUJALKALI Q3 Net Loss of ₹11 Cr; Board Approves ₹1,029 Cr Capex for Expansion and Energy Projects
GUJALKALI reported a standalone net loss of ₹11.16 crore for Q3 FY26, down from a profit of ₹16.28 crore in the previous quarter, despite a revenue of ₹1,044 crore. To drive future growth, the board approved a massive ₹1,029 crore capital expenditure plan, including a new ₹560 crore Food Grade Phosphoric Acid plant at Dahej. Other major approvals include a ₹389 crore investment in energy-efficient boilers and an ₹80 crore expansion of Caustic Potash capacity. The company also secured a ₹250 crore line of credit to support these initiatives.
Key Highlights
Approved ₹560 crore for a 33,870 TPA Food Grade Phosphoric Acid plant, expected to add ₹350 crore in annual revenue.
Investing ₹389 crore in four Biofuel/Coal fired boilers to generate 12 MW power and reduce steam costs.
Expanding Caustic Potash (KOH) capacity from 120 TPD to 200 TPD at Vadodara with an ₹80 crore investment.
Reported a standalone net loss of ₹11.16 crore for Q3 FY26 compared to a profit of ₹16.28 crore in Q2 FY26.
Board approved availing a ₹250 crore Line of Credit from Gujarat State Financial Services Ltd (GSFS).
👀 What to Watch
Investors should weigh the current quarterly loss against the significant long-term growth potential from the ₹1,000+ crore capex projects. Monitor the execution timelines of the Phosphoric Acid plant and the impact of cost-saving boiler installations on future margins.
GUJALKALI Reports Q3 Loss; Approves ₹1,029 Crore Capex for Expansion and Energy Projects
Gujarat Alkalies and Chemicals Limited (GACL) reported a consolidated net loss of ₹19.95 crore for Q3 FY26, down from a profit of ₹16.34 crore in the preceding quarter. To drive future growth, the board approved a massive ₹1,029 crore capital expenditure plan, including a new ₹560 crore Phosphoric Acid plant and ₹389 crore for energy-efficient boilers. The company is also expanding its Caustic Potash capacity from 120 TPD to 200 TPD at an investment of ₹80 crore. To support these initiatives, a ₹250 crore line of credit from GSFS has been approved.
Key Highlights
Reported a consolidated net loss of ₹19.95 crore in Q3 FY26 versus a profit of ₹16.34 crore in Q2 FY26.
Approved ₹560 crore for a 33,870 TPA Food Grade Phosphoric Acid plant, projected to add ₹350 crore to annual revenue.
Investing ₹389 crore in four Bio-fuel/Coal fired boilers to generate 12 MW power and reduce steam costs.
Expanding Caustic Potash (KOH) capacity from 120 TPD to 200 TPD with an expected revenue increase of ₹130 crore.
Secured a ₹250 crore Line of Credit facility from Gujarat State Financial Services Ltd for financial flexibility.
👀 What to Watch
Investors should weigh the current quarterly loss against the significant long-term revenue potential of the ₹1,029 crore expansion projects. Monitor the implementation timelines of the Phosphoric Acid plant and the cost-saving boilers as they are key to margin recovery.
GACL Reports Q3 Loss; Approves Rs 1,029 Cr Expansion Projects & Rs 250 Cr Credit Line
Gujarat Alkalies and Chemicals (GACL) reported a consolidated net loss of Rs 19.95 crore for Q3 FY26, down from a profit of Rs 16.34 crore in the previous quarter. To drive future growth, the board approved major CAPEX projects totaling approximately Rs 1,029 crore, including a new Phosphoric Acid plant and energy-efficient boilers. The company also secured a Rs 250 crore line of credit from GSFS to bolster its liquidity. While current earnings are under pressure, the planned expansions target an additional annual revenue of over Rs 480 crore upon completion.
Key Highlights
Approved Rs 560 crore for a 33,870 TPA Food Grade Phosphoric Acid Plant at Dahej with Rs 350 crore revenue potential.
Investing Rs 389 crore in four bio-fuel/coal boilers to generate 12 MW power and significantly reduce steam costs.
Expanding Caustic Potash (KOH) capacity from 120 TPD to 200 TPD at Vadodara for Rs 80 crore.
Consolidated Q3 FY26 net loss stood at Rs 19.95 crore vs a profit of Rs 16.34 crore in Q2 FY26.
Board approved availing a Rs 250 crore Line of Credit facility from Gujarat State Financial Services Ltd.
👀 What to Watch
Investors should look past the temporary quarterly loss and focus on the massive CAPEX pipeline which aims to diversify the product mix and reduce energy costs. Monitor the execution timelines of the Phosphoric Acid plant as it is a significant revenue driver.
GUJALKALI Q3 Loss Widens to ₹73.9 Cr; Board Approves ₹1,029 Cr Expansion Projects
GUJALKALI reported a consolidated net loss of ₹73.94 crore for Q3 FY26, a significant decline from a profit of ₹16.34 crore in the preceding quarter. Despite the weak quarterly performance, the board has approved massive capital expenditures totaling approximately ₹1,029 crore to drive future growth and cost efficiency. These projects include a new ₹560 crore Phosphoric Acid plant and a ₹389 crore investment in energy-efficient boilers. The company also secured a ₹250 crore line of credit from Gujarat State Financial Services to support its operations and expansion.
Key Highlights
Consolidated net loss stood at ₹73.94 crore for Q3 FY26 compared to a profit of ₹16.34 crore in Q2 FY26.
Approved ₹560 crore for a 33,870 TPA Food Grade Phosphoric Acid Plant at Dahej, expected to add ₹350 crore in annual revenue.
Investing ₹389 crore in four bio-fuel/coal-fired boilers to generate 12 MW power and substantially reduce steam costs.
Expanding Caustic Potash (KOH) capacity from 120 TPD to 200 TPD at Vadodara with an investment of ₹80 crore.
Board approved availing a ₹250 crore Line of Credit from Gujarat State Financial Services Ltd (GSFS).
👀 What to Watch
While the current earnings reflect significant margin pressure and operational losses, the large-scale CAPEX indicates a strong long-term growth outlook. Investors should monitor the execution timelines of the new plants and the impact of cost-saving boilers on future margins.
